Report Detail

Other Global Active Pharmaceutical Ingredients (API) Market Research Report 2019

  • RnM2881814
  • |
  • 05 February, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Other

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.
Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.

The global Active Pharmaceutical Ingredients (API) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Active Pharmaceutical Ingredients (API) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Active Pharmaceutical Ingredients (API) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Synthetic APIs
Biotech APIs

Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others


Table of Contents

    Executive Summary

      1 Active Pharmaceutical Ingredients (API) Market Overview

      • 1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API)
      • 1.2 Active Pharmaceutical Ingredients (API) Segment by Type
        • 1.2.1 Global Active Pharmaceutical Ingredients (API) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Synthetic APIs
        • 1.2.3 Biotech APIs
      • 1.3 Active Pharmaceutical Ingredients (API) Segment by Application
        • 1.3.1 Active Pharmaceutical Ingredients (API) Consumption Comparison by Application (2014-2025)
        • 1.3.2 CNS
        • 1.3.3 Cardiovascular
        • 1.3.4 Genitourinary/Hormonal Drugs
        • 1.3.5 Respiratory
        • 1.3.6 Rheumatology
        • 1.3.7 Diabetes
        • 1.3.8 Oncology
        • 1.3.9 Others
      • 1.3 Global Active Pharmaceutical Ingredients (API) Market by Region
        • 1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Active Pharmaceutical Ingredients (API) Market Size
        • 1.4.1 Global Active Pharmaceutical Ingredients (API) Revenue (2014-2025)
        • 1.4.2 Global Active Pharmaceutical Ingredients (API) Production (2014-2025)

      2 Global Active Pharmaceutical Ingredients (API) Market Competition by Manufacturers

      • 2.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Types
      • 2.5 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
        • 2.5.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
        • 2.5.2 Active Pharmaceutical Ingredients (API) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions

      • 3.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions
      • 3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Active Pharmaceutical Ingredients (API) Production
        • 3.4.1 North America Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
        • 3.4.2 North America Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Active Pharmaceutical Ingredients (API) Production
        • 3.5.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Active Pharmaceutical Ingredients (API) Production (2014-2019)
        • 3.6.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
        • 3.6.2 China Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Active Pharmaceutical Ingredients (API) Production (2014-2019)
        • 3.7.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Active Pharmaceutical Ingredients (API) Consumption by Regions

      • 4.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
      • 4.2 North America Active Pharmaceutical Ingredients (API) Consumption (2014-2019)
      • 4.3 Europe Active Pharmaceutical Ingredients (API) Consumption (2014-2019)
      • 4.4 China Active Pharmaceutical Ingredients (API) Consumption (2014-2019)
      • 4.5 Japan Active Pharmaceutical Ingredients (API) Consumption (2014-2019)

      5 Global Active Pharmaceutical Ingredients (API) Production, Revenue, Price Trend by Type

      • 5.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2014-2019)
      • 5.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2014-2019)
      • 5.4 Global Active Pharmaceutical Ingredients (API) Production Growth by Type (2014-2019)

      6 Global Active Pharmaceutical Ingredients (API) Market Analysis by Applications

      • 6.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business

      • 7.1 Teva
        • 7.1.1 Teva Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.1.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.1.3 Teva Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Mylan
        • 7.2.1 Mylan Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.2.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.2.3 Mylan Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 DSM
        • 7.3.1 DSM Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.3.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.3.3 DSM Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Aurobindo Pharma
        • 7.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.4.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Aspen
        • 7.5.1 Aspen Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.5.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.5.3 Aspen Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis
        • 7.6.1 Novartis Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.6.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.6.3 Novartis Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 BASF
        • 7.7.1 BASF Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.7.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.7.3 BASF Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Pfizer
        • 7.8.1 Pfizer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.8.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Huahai Pharmaceutical
        • 7.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.9.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Hisun Pharmaceutical
        • 7.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
        • 7.10.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
        • 7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Sun Pharmaceutical Industries
      • 7.12 Zhejiang Medicine
      • 7.13 Dr. Reddy’s Laboratories
      • 7.14 Zhejiang NHU
      • 7.15 Bayer
      • 7.16 NCPC
      • 7.17 AbbVie
      • 7.18 Shandong Xinhua Pharmaceutical
      • 7.19 Northeast Pharm
      • 7.20 Harbin Pharmaceutical
      • 7.21 LKPC

      8 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis

      • 8.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
      • 8.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Active Pharmaceutical Ingredients (API) Distributors List
      • 9.3 Active Pharmaceutical Ingredients (API) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Active Pharmaceutical Ingredients (API) Market Forecast

      • 11.1 Global Active Pharmaceutical Ingredients (API) Production, Revenue Forecast
        • 11.1.1 Global Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2019-2025)
      • 11.2 Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Active Pharmaceutical Ingredients (API) Consumption Forecast (2019-2025)
        • 11.3.3 China Active Pharmaceutical Ingredients (API) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Active Pharmaceutical Ingredients (API) Consumption Forecast (2019-2025)
      • 11.4 Global Active Pharmaceutical Ingredients (API) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Active Pharmaceutical Ingredients (API) . Industry analysis & Market Report on Active Pharmaceutical Ingredients (API) is a syndicated market report, published as Global Active Pharmaceutical Ingredients (API) Market Research Report 2019. It is complete Research Study and Industry Analysis of Active Pharmaceutical Ingredients (API) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,241.70
        3,362.55
        4,483.40
        2,699.90
        4,049.85
        5,399.80
        442,801.00
        664,201.50
        885,602.00
        244,760.00
        367,140.00
        489,520.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report